Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Beta-endorphin binding activity of SP-40,40

N H Choi-Miura1, Y Nakano, T Tobe

  • 1Department of Physiological Chemistry, School of Pharmaceutical Sciences, Showa University, Tokyo, Japan.

Biological & Pharmaceutical Bulletin
|March 1, 1993
PubMed
Summary

SP-40,40 binds to beta-endorphin, a peptide hormone, and may inhibit its receptor binding. This interaction suggests SP-40,40 could modulate the biological effects of beta-endorphin.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cloning of the cDNA encoding a novel rat mast-cell proteinase, rMCP-3, and its expression in comparison with other rat mast-cell proteinases.

The Biochemical journal·1995
Same author

[Surgical treatment of advanced renal cell carcinoma].

Nihon Hinyokika Gakkai zasshi. The japanese journal of urology·1995
Same author

[Clinical characteristics of 7 renal cell carcinoma patients developing a solitary pancreatic metastasis after nephrectomy].

Nihon Hinyokika Gakkai zasshi. The japanese journal of urology·1995
Same author

Molecular cloning of mouse intestinal trefoil factor and its expression during goblet cell changes.

The Biochemical journal·1995
Same author

[Primary and experimental study of a new treatment for hepatolithiasis by injection of resin in the intrahepatic bile duct].

Nihon Geka Gakkai zasshi·1995
Same author

Mutation in aspartic acid residues modifies catalytic and haemolytic activities of Bacillus cereus sphingomyelinase.

The Biochemical journal·1995

Area of Science:

  • Biochemistry
  • Immunology
  • Neuroscience

Background:

  • Beta-endorphin is a key endogenous opioid peptide involved in pain relief and mood regulation.
  • SP-40,40 (also known as vitronectin) is a cell adhesion protein with diverse biological functions.
  • The soluble membrane attack complex (SMAC, SC5b-9) is a} component of the complement system.

Purpose of the Study:

  • To investigate the binding interactions between SP-40,40, beta-endorphin, and the complement system.
  • To determine if SP-40,40 influences the interaction of beta-endorphin with its cellular receptors.

Main Methods:

  • Cross-linking experiments using radiolabeled [125I] beta-endorphin.
  • Autoradiography to detect protein-protein interactions within the SMAC.
  • Inhibition assays to assess beta-endorphin receptor binding.

Related Experiment Videos

Main Results:

  • SP-40,40 was found to bind to the C-terminal non-opioid portion of beta-endorphin.
  • Beta-endorphin primarily bound to SP-40,40 within the SMAC, not to S-protein (vitronectin).
  • SP-40,40 binding to beta-endorphin inhibited the binding of beta-endorphin to its receptor in rat brain tissue.

Conclusions:

  • SP-40,40 interacts with beta-endorphin and may play a role in modulating its biological activity.
  • The binding interaction occurs within the context of the complement system's SMAC.
  • SP-40,40 has the potential to inhibit the physiological functions of beta-endorphin.